Dr. Devitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1240 Lee St
Charlottesville, VA 22908Phone+1 434-924-9333Fax+1 434-244-7526
Education & Training
- University of Virginia Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
- University of Virginia Medical CenterResidency, Internal Medicine, 2014 - 2015
- Indiana University School of MedicineClass of 2011
Certifications & Licensure
- VA State Medical License 2011 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Impact of Renin-Angiotensin System Inhibitors on Response to PD1/L1 Inhibitors in Patients With Metastatic Renal Cell Carcinoma.Kathryn Fortune, Soham Ali, Jack Masur, Paul Viscuse, Michael Devitt
Clinical Genitourinary Cancer. 2024-11-01 - 1 citationsImpact of DPP4 Inhibition on Survival in Patients With Metastatic Renal Cell Carcinoma and Type 2 Diabetes Mellitus.Soham Ali, Kathryn Fortune, Jack Masur, Paul Vincent Viscuse, Michael Edward Devitt
Clinical Genitourinary Cancer. 2024-10-01 - Clinical Management of Advanced Prostate Cancer: Where Does Radiopharmaceutical Therapy Fit in the Treatment Algorithm?Paul Viscuse, Michael Devitt, Robert Dreicer
Journal of Nuclear Medicine. 2024-05-01
Press Mentions
- New Tools Guide Lifestyle Medicine Integration for FPsJune 3rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: